Total Valuation
Dexcom has a market cap or net worth of CHF25.47B. The enterprise value is CHF25.72K.
Market CapCHF25.47B
Enterprise ValueCHF25.72K
Share Statistics
Dexcom has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding―
Owned by Insiders0.42%
Owned by Institutions4.36%
Financial Efficiency
Dexcom’s return on equity (ROE) is 0.30 and return on invested capital (ROIC) is 16.61%.
Return on Equity (ROE)0.30
Return on Assets (ROA)0.13
Return on Invested Capital (ROIC)16.61%
Return on Capital Employed (ROCE)0.22
Revenue Per Employee420.00K
Profits Per Employee75.34K
Employee Count11,100
Asset Turnover0.74
Inventory Turnover2.96
Valuation Ratios
The current PE Ratio of Dexcom is 32.2. Dexcom’s PEG ratio is 0.67.
PE Ratio32.2
PS Ratio5.56
PB Ratio9.43
Price to Fair Value9.43
Price to FCF24.04
Price to Operating Cash Flow18.14
PEG Ratio0.67
Income Statement
In the last 12 months, Dexcom had revenue of 4.66B and earned 836.30M in profits. Earnings per share was 2.14.
Revenue4.66B
Gross Profit2.80B
Operating Income911.80M
Pretax Income1.09B
Net Income836.30M
EBITDA1.36B
Earnings Per Share (EPS)2.14
Cash Flow
In the last 12 months, operating cash flow was 1.75B and capital expenditures -343.70M, giving a free cash flow of 1.41B billion.
Operating Cash Flow1.75B
Free Cash Flow1.41B
Free Cash Flow per Share10.00T>
Dividends & Yields
Dexcom pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta―
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Dexcom upcoming earnings date is Oct 22, 2026, After Close (Confirmed).
Last Earnings DateJul 30, 2026
Next Earnings DateOct 22, 2026
Ex-Dividend Date―
Financial Position
Dexcom as a current ratio of 1.88, with Debt / Equity ratio of 53.35%
Current Ratio1.88
Quick Ratio1.59
Debt to Market Cap0.05
Net Debt to EBITDA0.35
Interest Coverage Ratio49.83
Taxes
In the past 12 months, Dexcom has paid 252.10M in taxes.
Income Tax252.10M
Effective Tax Rate0.23
Enterprise Valuation
Dexcom EV to EBITDA ratio is 19.41, with an EV/FCF ratio of 24.48.
EV to Sales5.66
EV to EBITDA19.41
EV to Free Cash Flow24.48
EV to Operating Cash Flow18.30
Balance Sheet
Dexcom has CHF1.95B in cash and marketable securities with CHF1.40B in debt, giving a net cash position of CHF548.60M billion.
Cash & Marketable SecuritiesCHF1.95B
Total DebtCHF1.40B
Net CashCHF548.60M
Net Cash Per ShareCHF10.00T>
Tangible Book Value Per ShareCHF6.79
Margins
Gross margin is 62.47%, with operating margin of 19.56%, and net profit margin of 17.94%.
Gross Margin62.47%
Operating Margin19.56%
Pretax Margin23.35%
Net Profit Margin17.94%
EBITDA Margin29.14%
EBIT Margin23.74%
Analyst Forecast
The average price target for Dexcom is CHF73.21, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetCHF73.21
Price Target Upside― Upside
Analyst ConsensusStrong Buy
Analyst Count23
Revenue Growth Forecast―
EPS Growth Forecast―